Goal 2: Reduce Human Disease

Cardovascular risk and Microparticles in GOLD Class A/B COPD?

Can Measuring CD31+EMPs predict loss of lung function, provide potential bio marker for accelerated lung function loss, and predict increased risk for atherosclerosis leading to increased risk for cardiovascular events?

Tags (Keywords associated with the idea)

Is this idea a Compelling Question (CQ) or Critical Challenge (CC)? : Compelling Question (CQ)

Details on the impact of addressing this CQ or CC :

Fosters primary prevention and secondary prevention interventions to affect disease development and progression. Potentially, advances the understanding of the link between advancing loss of lung function, a novel biomarker assay to assess exacerbations and their link to increased cardiovascular events found in patients with COPD.

Voting

4 net votes
8 up votes
4 down votes
Active
Idea No. 826